Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
35,033
archived clinical trials in
Lung Cancer

Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib
Randomized Phase II Trial of Sorafenib and Erlotinib or Sorafenib Alone in Patients With Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib
Status: Enrolling
Updated:  3/10/2016
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib
Randomized Phase II Trial of Sorafenib and Erlotinib or Sorafenib Alone in Patients With Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib
Status: Enrolling
Updated: 3/10/2016
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
Ironwood Cancer and Research Centers SC
mi
from
Chandler, AZ
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
Ironwood Cancer and Research Centers SC
mi
from
Chandler, AZ
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
Arizona Oncology Associates Tucson (Rudasill & La Cholla)
mi
from
Phoenix, AZ
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
Arizona Oncology Associates Tucson (Rudasill & La Cholla)
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
Highlands Oncology Group Dept of Highlands Oncology Grp
mi
from
Fayetteville, AR
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
Highlands Oncology Group Dept of Highlands Oncology Grp
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
Cedars Sinai Medical Center Dept.of Cedars-Sinai Med. Ctr.
mi
from
Los Angeles, CA
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
Cedars Sinai Medical Center Dept.of Cedars-Sinai Med. Ctr.
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
University of California at San Diego, Moores Cancer Ctr SC
mi
from
San Diego, CA
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
University of California at San Diego, Moores Cancer Ctr SC
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
University of Colorado Univ CO
mi
from
Aurora, CO
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
University of Colorado Univ CO
mi
from
Aurora, CO
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
Rocky Mountain Cancer Centers Dept. of Rocky Mountain Cancer
mi
from
Greenwood Village, CO
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
Rocky Mountain Cancer Centers Dept. of Rocky Mountain Cancer
mi
from
Greenwood Village, CO
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
H. Lee Moffitt Cancer Center & Research Institute H Lee Moffitt
mi
from
Tampa, FL
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
H. Lee Moffitt Cancer Center & Research Institute H Lee Moffitt
mi
from
Tampa, FL
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
Emory University School of Medicine/Winship Cancer Institute Emory 2
mi
from
Atlanta, GA
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
Emory University School of Medicine/Winship Cancer Institute Emory 2
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
University of Chicago Medical Center Unvi Chi
mi
from
Chicago, IL
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
University of Chicago Medical Center Unvi Chi
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
Rush University Medical Center SC
mi
from
Chicago, IL
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
Rush University Medical Center SC
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
University of Kansas Cancer Center Univ of KS
mi
from
Kansas City, KA
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
University of Kansas Cancer Center Univ of KS
mi
from
Kansas City, KA
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
Massachusetts General Hospital Mass General
mi
from
Boston, MA
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
Massachusetts General Hospital Mass General
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
Hematology Oncology Associates of Northern New Jersey PA DeptofHem-OncofNorthern NJ (2)
mi
from
Morristown, NJ
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
Hematology Oncology Associates of Northern New Jersey PA DeptofHem-OncofNorthern NJ (2)
mi
from
Morristown, NJ
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
Overlook Hospital - Carol G Simon Cancer Center Carol G Simon
mi
from
Summit, NJ
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
Overlook Hospital - Carol G Simon Cancer Center Carol G Simon
mi
from
Summit, NJ
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
Roswell Park Cancer Institute Rosewell
mi
from
Buffalo, NY
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
Roswell Park Cancer Institute Rosewell
mi
from
Buffalo, NY
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
Duke University Medical Center Duke 2
mi
from
Durham, NC
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
Duke University Medical Center Duke 2
mi
from
Durham, NC
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
MetroHealth Medical Center Dept.ofMetroHealthMedCtr.(2)
mi
from
Cleveland, OH
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
MetroHealth Medical Center Dept.ofMetroHealthMedCtr.(2)
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
University of Oklahoma Health Sciences Center Dept. of Oklahoma Univ. HSC
mi
from
Oklahoma City, OK
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
University of Oklahoma Health Sciences Center Dept. of Oklahoma Univ. HSC
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
Northwest Cancer Specialists Compass Oncology -BKM
mi
from
Portland, OR
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
Northwest Cancer Specialists Compass Oncology -BKM
mi
from
Portland, OR
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
University of Pittsburgh Medical Center SC-2
mi
from
Pittsburgh, PA
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
University of Pittsburgh Medical Center SC-2
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
Medical University of South Carolina
mi
from
Charleston, SC
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
Baylor Health Care System / Sammons Cancer Center Baylor Texas Oncology
mi
from
Dallas, TX
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
Baylor Health Care System / Sammons Cancer Center Baylor Texas Oncology
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
U of TX Southwestern Medical Center - SimmonsCompCancerCtr Clinical Research Office
mi
from
Dallas, TX
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
U of TX Southwestern Medical Center - SimmonsCompCancerCtr Clinical Research Office
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
Virginia Oncology Associates VOA - Lake Wright (2)
mi
from
*see Various Departments*, VA
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
Virginia Oncology Associates VOA - Lake Wright (2)
mi
from
*see Various Departments*, VA
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
University of Wisconsin Univ WIsc 2
mi
from
Madison, WI
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
University of Wisconsin Univ WIsc 2
mi
from
Madison, WI
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
Mayo Clinic - Arizona Mayo Scottsdale AZ
mi
from
Scottsdale, AZ
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
Mayo Clinic - Arizona Mayo Scottsdale AZ
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
Fallon Clinic at Worcester Medical Center Fallon Clinic Worcester Med
mi
from
Worcester, MA
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
Fallon Clinic at Worcester Medical Center Fallon Clinic Worcester Med
mi
from
Worcester, MA
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
Karmanos Cancer Institute Wayne St Karmanos
mi
from
Detroit, MI
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
Karmanos Cancer Institute Wayne St Karmanos
mi
from
Detroit, MI
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
Washington University School of Medicine Washington University (16)
mi
from
St. Louis, MO
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
Washington University School of Medicine Washington University (16)
mi
from
St. Louis, MO
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
Memorial Sloan Kettering Cancer Center Sloan Kettering
mi
from
NY, NY
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
Memorial Sloan Kettering Cancer Center Sloan Kettering
mi
from
NY, NY
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
Texas Oncology South Texas Oncology
mi
from
Dallas, TX
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
Texas Oncology South Texas Oncology
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated:  3/10/2016
Novartis Investigative Site
mi
from
Rio Negro,
Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway
Status: Enrolling
Updated: 3/10/2016
Novartis Investigative Site
mi
from
Rio Negro,
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
St. Vincent Birmingham & St. Vincent East
mi
from
Birmingham, AL
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
St. Vincent Birmingham & St. Vincent East
mi
from
Birmingham, AL
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
Jacksonville Center for Research
mi
from
Jacksonville, FL
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
Jacksonville Center for Research
mi
from
Jacksonville, FL
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
Moffit Cancer Center
mi
from
Tampa, FL
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
Moffit Cancer Center
mi
from
Tampa, FL
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
WellStar Research Institute
mi
from
Atlanta, GA
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
WellStar Research Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
Emory University
mi
from
Atlanta, GA
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
Indiana University
mi
from
Indianapolis, IN
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
St. Vincent Hospital and Health Care Center
mi
from
Indianapolis, IN
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
St. Vincent Hospital and Health Care Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
Greater Baltimore Medical Center
mi
from
Baltimore, MD
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
Greater Baltimore Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
Mass General Hospital
mi
from
Boston, MA
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
Mass General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
Brigham and Women's Hosp
mi
from
Boston, MA
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
Beth Israel Deconess Medical Center
mi
from
Boston, MA
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
Beth Israel Deconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
The Mayo Clinic
mi
from
Rochester, MN
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
Lancaster General Hospital
mi
from
Lancaster, PA
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
Lancaster General Hospital
mi
from
Lancaster, PA
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
VCU Medical Center
mi
from
Richmond, VA
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
VCU Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated:  3/14/2016
Swedish Cancer Institute
mi
from
Seattle, WA
NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study
AirTight: A Prospective Controlled Post-Approval Study of NeoMend ProGEL™ Pleural Air Leak Sealant in the Treatment of Visible Pleural Air Leaks After Standard Pleural Closure
Status: Enrolling
Updated: 3/14/2016
Swedish Cancer Institute
mi
from
Seattle, WA
Click here to add this to my saved trials